| Name | GSK-2793660 |
|---|
| Description | GSK-2793660 is an oral, irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 can be used for the research of bronchiectasis[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Cathepsin C (CTSC)[1][2] |
| In Vivo | GSK-2793660 is a cathepsin C (also known as dipeptidyl peptidase I enzyme) inhibitor for the reaearch of cystic fibrosis, non-cystic fibrosis bronchiectasis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and bronchiectasis[1]. |
| References |
| Molecular Formula | C20H27N3O3 |
|---|---|
| Molecular Weight | 357.45 |